ECPELLA as a  bridge-to-decision in refractory cardiogenic shock: a single-centre experience
CONCLUSION: ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.PMID:38713449 | DOI:10.1007/s12471-024-01872-w (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Jan-Willem Balder Mariusz K Szymanski Linda W van Laake Pim van der Harst Christiaan L Meuwese Faiz Z Ramjankhan Manon G van der Meer Jeannine A J M Hermens Michiel Voskuil Eric E C de Waal Dirk W Donker Marish I F J Oerlemans Adriaan O Kraaijeveld Source Type: research

A  quest to unravel idiopathic ventricular fibrillation
Neth Heart J. 2024 May 7. doi: 10.1007/s12471-024-01874-8. Online ahead of print.NO ABSTRACTPMID:38713450 | DOI:10.1007/s12471-024-01874-8 (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Joris R de Groot Source Type: research

ECPELLA as a  bridge-to-decision in refractory cardiogenic shock: a single-centre experience
CONCLUSION: ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.PMID:38713449 | DOI:10.1007/s12471-024-01872-w (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Jan-Willem Balder Mariusz K Szymanski Linda W van Laake Pim van der Harst Christiaan L Meuwese Faiz Z Ramjankhan Manon G van der Meer Jeannine A J M Hermens Michiel Voskuil Eric E C de Waal Dirk W Donker Marish I F J Oerlemans Adriaan O Kraaijeveld Source Type: research

A  quest to unravel idiopathic ventricular fibrillation
Neth Heart J. 2024 May 7. doi: 10.1007/s12471-024-01874-8. Online ahead of print.NO ABSTRACTPMID:38713450 | DOI:10.1007/s12471-024-01874-8 (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Joris R de Groot Source Type: research

ECPELLA as a  bridge-to-decision in refractory cardiogenic shock: a single-centre experience
CONCLUSION: ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.PMID:38713449 | DOI:10.1007/s12471-024-01872-w (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Jan-Willem Balder Mariusz K Szymanski Linda W van Laake Pim van der Harst Christiaan L Meuwese Faiz Z Ramjankhan Manon G van der Meer Jeannine A J M Hermens Michiel Voskuil Eric E C de Waal Dirk W Donker Marish I F J Oerlemans Adriaan O Kraaijeveld Source Type: research

A  quest to unravel idiopathic ventricular fibrillation
Neth Heart J. 2024 May 7. doi: 10.1007/s12471-024-01874-8. Online ahead of print.NO ABSTRACTPMID:38713450 | DOI:10.1007/s12471-024-01874-8 (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Joris R de Groot Source Type: research

ECPELLA as a  bridge-to-decision in refractory cardiogenic shock: a single-centre experience
CONCLUSION: ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.PMID:38713449 | DOI:10.1007/s12471-024-01872-w (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Jan-Willem Balder Mariusz K Szymanski Linda W van Laake Pim van der Harst Christiaan L Meuwese Faiz Z Ramjankhan Manon G van der Meer Jeannine A J M Hermens Michiel Voskuil Eric E C de Waal Dirk W Donker Marish I F J Oerlemans Adriaan O Kraaijeveld Source Type: research

A  quest to unravel idiopathic ventricular fibrillation
Neth Heart J. 2024 May 7. doi: 10.1007/s12471-024-01874-8. Online ahead of print.NO ABSTRACTPMID:38713450 | DOI:10.1007/s12471-024-01874-8 (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Joris R de Groot Source Type: research

ECPELLA as a  bridge-to-decision in refractory cardiogenic shock: a single-centre experience
CONCLUSION: ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.PMID:38713449 | DOI:10.1007/s12471-024-01872-w (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Jan-Willem Balder Mariusz K Szymanski Linda W van Laake Pim van der Harst Christiaan L Meuwese Faiz Z Ramjankhan Manon G van der Meer Jeannine A J M Hermens Michiel Voskuil Eric E C de Waal Dirk W Donker Marish I F J Oerlemans Adriaan O Kraaijeveld Source Type: research

A  quest to unravel idiopathic ventricular fibrillation
Neth Heart J. 2024 May 7. doi: 10.1007/s12471-024-01874-8. Online ahead of print.NO ABSTRACTPMID:38713450 | DOI:10.1007/s12471-024-01874-8 (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Joris R de Groot Source Type: research

ECPELLA as a  bridge-to-decision in refractory cardiogenic shock: a single-centre experience
CONCLUSION: ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.PMID:38713449 | DOI:10.1007/s12471-024-01872-w (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Jan-Willem Balder Mariusz K Szymanski Linda W van Laake Pim van der Harst Christiaan L Meuwese Faiz Z Ramjankhan Manon G van der Meer Jeannine A J M Hermens Michiel Voskuil Eric E C de Waal Dirk W Donker Marish I F J Oerlemans Adriaan O Kraaijeveld Source Type: research

A  quest to unravel idiopathic ventricular fibrillation
Neth Heart J. 2024 May 7. doi: 10.1007/s12471-024-01874-8. Online ahead of print.NO ABSTRACTPMID:38713450 | DOI:10.1007/s12471-024-01874-8 (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Joris R de Groot Source Type: research

ECPELLA as a  bridge-to-decision in refractory cardiogenic shock: a single-centre experience
CONCLUSION: ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.PMID:38713449 | DOI:10.1007/s12471-024-01872-w (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Jan-Willem Balder Mariusz K Szymanski Linda W van Laake Pim van der Harst Christiaan L Meuwese Faiz Z Ramjankhan Manon G van der Meer Jeannine A J M Hermens Michiel Voskuil Eric E C de Waal Dirk W Donker Marish I F J Oerlemans Adriaan O Kraaijeveld Source Type: research

A  quest to unravel idiopathic ventricular fibrillation
Neth Heart J. 2024 May 7. doi: 10.1007/s12471-024-01874-8. Online ahead of print.NO ABSTRACTPMID:38713450 | DOI:10.1007/s12471-024-01874-8 (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Joris R de Groot Source Type: research

ECPELLA as a  bridge-to-decision in refractory cardiogenic shock: a single-centre experience
CONCLUSION: ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.PMID:38713449 | DOI:10.1007/s12471-024-01872-w (Source: Netherlands Heart Journal)
Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Jan-Willem Balder Mariusz K Szymanski Linda W van Laake Pim van der Harst Christiaan L Meuwese Faiz Z Ramjankhan Manon G van der Meer Jeannine A J M Hermens Michiel Voskuil Eric E C de Waal Dirk W Donker Marish I F J Oerlemans Adriaan O Kraaijeveld Source Type: research